Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 9, 1997

View Archived Issues

NK1 antagonist effective in rat model of focal cerebral ischemia

Attenuation of cyclophosphamide-induced bladder damage in animals by GR-203040

Inflazyme contracts Inveresk Research for IND support

New orally active immunosuppressant for combination with ciclosporin

Additional results for Bradycor in traumatic brain injury

Kosan receives NIH grant for macrolide antibiotic development

Schering-Plough seeks approval for pediatric indication of Intron A

Novastan granted priority review status by FDA

Preliminary results reported for RMP-7/carboplatin

Promising phase II results for Genzyme Transgenics' rhATIII

Pharmacia & Upjohn's urinary incontinence treatment approved in Sweden

Agents useful for BPH from Pfizer

Warner-Lambert/CoCensys develop neuroprotective agents

Osteoprotegerin: new polypeptide for bone diseases

Ribi seeks approval for melanoma vaccine in Canada

Ethnic differences in codeine's efficacy/side effects

Copaxone approved in Canada

SB-204269, an anticonvulsant with a unique mechanism of action

Resveratrol found in edible peanuts

RPR submits NDA for novel antibiotic

Nepicastat: a novel dopamine-beta-hydroxylase inhibitor for CHF

GSH prevents cisplatin-induced toxicity

Treatment for preleukemic disorder from Milkhaus enters phase III

Effects of AE-0047 on lipid profiles

CDR Therapeutics and CellGenEx merge to form Xcyte Therapies

(S)-(-)-OSU-6162 effective in monkey model of Parkinson's disease

Tolmetin eyedrop formulation evaluated in rabbits

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...